Status:
COMPLETED
Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
Lung cancer is the worldwide leading cause of cancer death. In France, with 28,000 new cases per year, lung cancer is the 4th in terms of incidence but remains the leading cause of cancer death. The 5...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- advanced unresectable non small cell lung cancer
- responding or stabilizer after induction chemotherapy
Exclusion
Key Trial Info
Start Date :
May 19 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2015
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT01159288
Start Date
May 19 2010
End Date
December 19 2015
Last Update
March 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Gustave Roussy
Villejuif, France, 94800